Oral Contraceptive Pills Global Market Report 2022 – Yahoo Finance

Kevin Heal and Steve Biggar of Argus Research share stocks that may benefit from rate hikes Wed., March 9 at 2 p.m. ET.
Major players in the oral contraceptive pills market are Teva Pharmaceutical Industries Ltd. , Bayer AG, Syzygy Healthcare, Mankind Pharma Ltd. , Pfizer Inc. , Piramal Enterprises Ltd. , Ferring B. V, Merck & Co.
New York, March 03, 2022 (GLOBE NEWSWIRE) — Reportlinker.com announces the release of the report "Oral Contraceptive Pills Global Market Report 2022" – https://www.reportlinker.com/p06241903/?utm_source=GNW
Inc., Johnson & Johnson and Lupin Pharmaceuticals Inc.

The global contraceptive pills market is expected to grow from $18.44 billion in 2021 to $20.13 billion in 2022 at a compound annual growth rate (CAGR) of 9.2%. The growth is mainly due to the companies resuming their operations and adapting to the new normal while recovering from the COVID-19 impact, which had earlier led to restrictive containment measures involving social distancing, remote working, and the closure of commercial activities that resulted in operational challenges. The market is expected to reach $31.92 billion in 2026 at a CAGR of 12.2%.

The oral contraceptive pills market consists of sales of oral contraceptive pills by entities (organizations, sole traders, and partnerships) that are engaged in manufacturing oral contraceptive pills.An oral contraceptive pill is a pill used to discourage pregnancy.

It comprises hormones that prevent the emergence of eggs from the ovaries. Most oral contraceptives involve estrogen and progestin.

The main types of oral contraceptive pills are combination, progestin only, others.Oral contraceptive pills that contain both estrogen and progestin are known as combination oral contraceptives.

Combination birth control pills prevent the ovaries from releasing an egg while also causing changes in the cervical mucus and uterine lining (endometrium) to prevent sperm from joining the egg. The various category of drugs include generic and branded that are distributed by hospital pharmacy, retail pharmacy, clinics, online channel, public channel and NGO, others.

The regions covered in this report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

The high incidence of unintended pregnancies is expected to drive the growth of the oral contraceptive pills market over the coming years.Unintended pregnancy is a pregnancy that is always unwanted, such as a pregnancy where no children have been planned.

The University of California, San Francisco (UCSF) study shows that the rates of unwanted pregnancy and abortion declined substantially when women received a one-year prescription of oral contraceptives.According to the World Health Organization (WHO), 74 million women living in low middle-income economies register unplanned pregnancies every year globally.

The WHO’s research noticed 4,794 women had an unplanned pregnancy after they had discontinued using contraceptives. Therefore, the need to avoid unintended pregnancies drives the growth of the oral contraceptive pills market.

The side effects associated with the use of contraceptive drugs are expected to hinder the growth of the oral contraceptive pills market over the forecast period.An oral contraceptive pill is a hormonal procedure to avoid childbirth.

The side effects vary between people and the type of pill consumed.Breast tenderness, headaches, spotting, and nausea are some prominent side effects of oral contraceptive pills.

Depo-Provera, an implantable contraceptive, is known to provide the most severe side effects.Research has indicated that Depo-Provera and Depo-SubQ Provera 104 can trigger bone mineral density loss.

The U.S. Food and Drug Administration (FDA) attached strict notices to the injection kit saying Depo-Provera and Depo-SubQ Provera 104 could not be used for more than 2 years, attributing to their side effects. The notice also suggests that the use of these medications may increase the risk of osteoporosis and bone disorders later in life. Hence, the side effects associated with the use of contraceptive drugs hamper the growth of the oral contraceptive pill market.

Major institutes and companies operating in the oral contraceptive pills sector are focusing on developing innovative solutions for oral contraceptive pills.For instance, in December 2019, a group of scientists from the Massachusetts Institute of Technology (MIT) has created a birth control pill that should only be consumed once a month.

The star-shaped capsule may significantly minimize accidental pregnancies caused by users who fail to take their regular dose of the pill. The capsule is filled with gelatin which may stay in the abdomen for weeks after swallowing, from where hormones are slowly released to stop childbirth.

In January 2020, Theramex, a specialty pharmaceutical company for women announced the acquisition of rights to Zoely®, a patented oral contraceptive from Merck &Co for an undisclosed amount.This acquisition aids Theramex in global expansion and adding innovative treatment options for women to its portfolio.

Merck & Co. is a US-based multinational pharmaceutical company that has oral contraceptives in its product portfolio.

The countries covered in the oral contraceptive pills market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK and USA.

Read the full report: https://www.reportlinker.com/p06241903/?utm_source=GNW

About Reportlinker
ReportLinker is an award-winning market research solution. Reportlinker finds and organizes the latest industry data so you get all the market research you need – instantly, in one place.

__________________________

Gilead unveiled mixed results for its drug Trodelvy in women with breast cancer on Monday — and GILD stock sank at the close.
Three Motley Fool contributors took at look at some biotech stocks that could make you richer in March (and beyond). Here's why they chose Axsome Therapeutics (NASDAQ: AXSM), Novocure (NASDAQ: NVCR), and Vertex Pharmaceuticals (NASDAQ: VRTX). Prosper Junior Bakiny (Axsome Therapeutics): With a market cap of about $1.2 billion, Axsome Therapeutics qualifies as a small-cap stock.
Tim Shanley, 32, from Sydney, shares with Men's Health how working out with Ultimate Performance helped him lose weight, get fit, and become healthier.
It’s understandable to have questions about N95 vs. KN95 masks. Infectious disease experts break it down, including which face masks offer the most protection against COVID-19 and how to find quality masks.
Studies suggest that certain blood types may leave you more at risk of COVID-19. See what the science says so far—and why people with Type O still need masks.
This week, Sen. Tim Kaine proposed a bill to aid people with Long COVID, the mysterious syndrome following a COVID infection that involves chronic, often debilitating symptoms. It's estimated that one-third to one-half of people who've had COVID go on to develop Long COVID. "That's going to put a burden on our health-care system," said Kaine, "and it's also going to require some research and some understanding, compassion, for people dealing with these symptoms — adjustments and accommodations i
A man having memory loss, slurred speech and imbalance comes to the emergency department at his concerned wife's urging. Dr. Kube orders a CT scan.
Hoosier Health column
Scientists have pinpointed 16 new genetic variants in people who developed severe COVID-19 in a large study published on Monday that could help researchers develop treatments for very sick patients. The results suggest that people with severe COVID have genes that predispose them to one of two problems: failure to limit the ability of the virus to make copies of itself, or excessive inflammation and blood clotting. "It is potentially possible in future that we will be able to make predictions about patients based on their genome at the point of presenting (for) critical care," said Kenneth Baillie, consultant in critical care medicine at the University of Edinburgh and one of the study authors, told reporters.
The bird flu outbreak is the worst since 2015, when nearly 50 million birds, mostly turkeys and egg-laying chickens in the U.S. Midwest, were killed. USDA reported the H5N1 strain in wild birds in the Carolinas earlier this year. Below are other outbreaks reported by USDA to date.
Vanessa Hudgens shows off her sculpted legs and abs in a see-through mini dress and hot pants at PFW on Instagram. Pilates and ballet classes help her stay fit.
Sen. Ron Johnson (R-Wis.) said in an interview Monday that the GOP should repeal and replace the Affordable Care Act, also known as Obamacare, if Republicans retake control of the White House and Congress in 2024.The big picture: The last time Republicans controlled the White House and Congress they were unable to successfully repeal and replace the ACA.Get market news worthy of your time with Axios Markets. Subscribe for free.Republicans made numerous efforts to repeal the health care law for a
After Stanford senior Katie Meyer, 22, committed suicide without any detectable warning signs, her parents are urging families to have an honest conversation about mental health with their children.
Now available! Drug Misuse in America 2021, our latest Health Trends® report, provides a unique snapshot of the pandemic's impact on drug misuse and health professionals’ critical need for comprehe…
Contracting the COVID-19 virus may result in damage to brain tissue and cognitive decline, according to new study released on Monday.Researchers from the University of Oxford looked into brain changes in 785 participants, who each received two brain scans, in the long-term UK Biobank study. Among the participants, 401 contracted the coronavirus between the two scans, giving researchers an opportunity to see changes between the first and second…
A Covid infection may shrink the brain, with degeneration happening three times faster than normal for middle-aged people, a new study suggests.
The actress best known for playing Lavender Brown says COVID-19 has hit her "like a ton of bricks for weeks."
As COVID-19 cases drop across the U.S. and more states announce an end to mask and vaccination mandates, it might seem like a return to business as usual. "As we get out of the full-blown pandemic phase of COVID-19, which we are certainly heading out of, these decisions will increasingly be made on a local level rather than centrally decided or mandated," says Dr. Anthony Fauci. "There will also be more people making their own decisions on how they want to deal with the virus." However, virus ex
Hong Kong is seeing a record number of net departures by residents as the city is battered by a runaway covid outbreak—and hamstrung by a government caught completely flatfooted in its pandemic response. For the past three weeks, there has been a net departure of over 20,000 residents each week, the highest levels in more than two years, according to numbers from the city’s immigration authorities and compiled by David Webb, a Hong Kong-based investor. For weeks now, government authorities have hinted—both in public and through leaks to the media—at a possible mainland-style lockdown in Hong Kong as a way to curb transmission and carry out a compulsory mass-testing campaign.
Stage 4 cancer patient turns to art to help himself heal

source

Leave a Comment

Your email address will not be published.

Shopping Cart